Nabriva Therapeutics plc Annual Operating Margin in % from 2016 to 2022

Taxonomy & unit: ratio: %
Description: The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary: Nabriva Therapeutics plc quarterly/annual Operating Margin history and growth rate from 2016 to 2022.
Nabriva Therapeutics plc Operating Margin for the quarter ending June 30, 2023 was -183 %, a 41.5% decline year-over-year.
Nabriva Therapeutics plc annual Operating Margin for 2022 was -150 %, a 10.5% increase from 2021.
Nabriva Therapeutics plc annual Operating Margin for 2021 was -168 %, a 87.2% increase from 2020.
Nabriva Therapeutics plc annual Operating Margin for 2020 was -1.32K %, a 56.9% decline from 2019.

Operating Margin, Annual (%)

Operating Margin, YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date
2022	-150	+17.7	+10.5%	Jan 1, 2022	Dec 31, 2022
2021	-168	+1.15K	+87.2%	Jan 1, 2021	Dec 31, 2021
2020	-1.32K	-477	-56.9%	Jan 1, 2020	Dec 31, 2020
2019	-838	+346	+29.2%	Jan 1, 2019	Dec 31, 2019
2018	-1.18K	+202	+14.6%	Jan 1, 2018	Dec 31, 2018
2017	-1.39K	-538	-63.3%	Jan 1, 2017	Dec 31, 2017
2016	-849			Jan 1, 2016	Dec 31, 2016

Showing 1 to 7 of 7 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.